Antidepressants for Depression

Antidepressants are prescription medicines that ease major depression by slowly steadying the brain chemistry behind it. They are not happy pills and not addictive, they take a few weeks to work, and they help millions of people recover.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Antidepressants Are and How They Help

Antidepressants are prescription medicines used to treat depression and several related conditions. They are a mainstay of care for moderate to severe major depressive disorder, and they work by gradually steadying the brain systems that depression disrupts[1].

If you are weighing whether to start one, or already take one and feel unsure about it, start here. Antidepressants are not happy pills, not personality changers, and not addictive in the way that word is usually meant[2]. They are a tool, and for many people a life-changing one.

Thinking about suicide or harming yourself? Help is here right now. Call or text 988, any time, free and confidential.
If you are thinking about suicide or about to hurt yourself, call or text 988 (the Suicide and Crisis Lifeline) for free, confidential support, any time.

What to do right now:

  • Reach a person. Call or text 988, or text HOME to 741741 (Crisis Text Line). You do not have to be sure you are in crisis to reach out.
  • Put distance between you and anything you could use to harm yourself. Ask someone you trust to hold pills or other means for now.
  • Ride out the wave. The worst of a suicidal urge often passes within minutes to hours. Stay near other people until it eases.
  • If someone has taken an overdose or is badly hurt, call 911.

Find depression and mental health treatment that fits →

AddictionHelp.com Fast Facts
  • They work for many people. A large network meta-analysis of 21 antidepressants found all of them more effective than placebo for adults with major depression[1].
  • They take time. Most antidepressants need roughly two to six weeks of steady use before the full effect shows, so early patience matters[3].
  • They are not addictive. People do not crave them or escalate the dose, though the body adjusts, so you taper off rather than stopping abruptly[2].
  • The first try is not the only try. About a third of people reach remission on the first medication, and switching or adding another lifts the odds[4].
  • Younger patients need closer watching. An FDA warning flags a small early rise in suicidal thoughts in people under 25, which calls for monitoring, not avoiding treatment[5].

Antidepressants Lift the Floor, They Do Not Erase Feelings

The most common fear about antidepressants is that they will flatten you or make you someone else. That is not how they work. At their best they lift the floor, easing the heaviness and restoring enough sleep, energy, and focus that ordinary life becomes reachable again.

They are not a chemical shortcut to happiness, and they do not numb you to a normal range of emotion. What they do is reduce the symptoms of an illness so the rest of recovery, including therapy and daily life, has room to work[6].

Who Antidepressants Help Most

Antidepressants help most in moderate to severe depression, where the evidence for benefit over placebo is clearest[1]. For mild depression, talk therapy is often tried first, and medication is added when symptoms are heavier or therapy alone is not enough.

They are also used for related conditions, including anxiety disorders and some chronic pain[7]. The right choice depends on your symptoms, your history, side effects you can live with, and your own preference, which is a conversation worth having openly with a prescriber.

How Antidepressants Work in the Brain

What rebalancing really meansAntidepressants nudge the brain’s chemistry, but relief seems to come from slower changes downstream, as brain circuits gradually strengthen and rewire. That deeper repair is part of why the effect builds over weeks rather than arriving the day you start.

Antidepressants act on the brain’s chemical messengers, but the full story is bigger and slower than the popular version. Understanding it helps explain why they take weeks to work and why no single drug fits everyone.

The Serotonin Imbalance Story Is Oversimplified

For decades depression was explained as a simple shortage of serotonin, the idea behind the monoamine hypothesis. Most antidepressants do raise serotonin or related chemicals, usually by blocking their reuptake[8].

But that “chemical imbalance” picture is now seen as incomplete[9]. The drugs change serotonin levels within hours, yet mood lifts only after weeks, which tells researchers something slower is doing the real work[10]. None of this means the drugs do not help. It means they help through more than one pathway.

Why Antidepressants Take Weeks, Not Days

The gap between taking a pill and feeling better is one of the hardest parts of starting treatment. Most antidepressants need about two to six weeks of steady use to show their full effect[3].

The leading explanation is that the lasting benefit comes from neuroplasticity, the slow strengthening and rewiring of brain connections that the early chemical change sets in motion[6]. The practical lesson is to give a new medication a fair trial of several weeks before judging it, unless side effects make that impossible.

The Main Classes of Antidepressants

There is no single antidepressant. There are several families, or classes, that work in different ways and carry different side effects. Knowing the landscape makes a prescriber’s choice less mysterious and easier to question.

Class How it works Common examples Notable effects
SSRIs Raise serotonin by blocking its reuptake Sertraline, escitalopram, fluoxetine First-line; nausea and sexual side effects are common, but generally well tolerated[11]
SNRIs Raise both serotonin and norepinephrine Venlafaxine, duloxetine First-line; can also ease some chronic pain, and venlafaxine has brisk discontinuation effects[7][12]
Atypicals Varied, outside the SSRI and SNRI patterns Bupropion, mirtazapine, trazodone, vortioxetine Bupropion is weight- and sex-neutral; mirtazapine aids sleep and appetite[13][14]
Tricyclics (TCAs) Block serotonin and norepinephrine reuptake, less selectively Amitriptyline, nortriptyline Effective but more side effects, and dangerous in overdose[15]
MAOIs Block the enzyme that breaks down monoamines Phenelzine, tranylcypromine Powerful for resistant cases, but need a special diet and have serious interactions[16]

SSRIs and SNRIs Are the Usual First Choice

Selective serotonin reuptake inhibitors, or SSRIs, are the most prescribed antidepressants and the usual starting point. Familiar names include sertraline, escitalopram, and fluoxetine, and they are favored because they balance solid effectiveness with reasonable tolerability[1].

SNRIs, such as venlafaxine and duloxetine, raise norepinephrine alongside serotonin, and they are a common second step or first choice when pain accompanies depression[7]. Both classes are effective, and the large comparison of 21 drugs found meaningful differences between individual agents in how well they work and how easily people stay on them[1].

Atypical Antidepressants Like Bupropion and Mirtazapine

Several useful antidepressants do not fit the SSRI or SNRI mold. Bupropion acts on dopamine and norepinephrine, and it stands out for not causing the sexual side effects or weight gain that bother some people on SSRIs, which is why it is often chosen or added for exactly that reason[13].

Mirtazapine works differently again, boosting serotonin and noradrenaline through a separate route, and its sedating, appetite-raising effects make it helpful when depression wrecks sleep and eating[14]. Trazodone is widely used in low doses for sleep[17], and vortioxetine is a newer option studied against standard drugs[18].

Older Classes Such as Tricyclics and MAOIs

The first antidepressants, discovered in the 1950s, were the tricyclics and the monoamine oxidase inhibitors[15]. They still work, and they still matter, but newer drugs largely replaced them as everyday first choices because they are easier to tolerate and safer.

Tricyclics like amitriptyline are effective and sometimes used for depression with chronic pain, but they cause more side effects and are dangerous in overdose[15]. MAOIs such as phenelzine remain a real option for stubborn depression, yet they require avoiding foods high in tyramine and carry serious drug interactions, so they are usually reserved for later steps[16].

How Well Antidepressants Work

A slow start is not a dead endNot responding to the first antidepressant is common and expected, not a sign you are untreatable. Each switch or addition lifts the cumulative odds of getting well, so persistence through the early steps is what gets most people there.

The real answer is that antidepressants help a lot of people, though not everyone, and rarely overnight. Holding both halves of that truth is the key to using them well.

What the Cipriani Network Meta-Analysis Found

The landmark evidence is a 2018 network meta-analysis that pooled 522 trials and more than 116,000 people across 21 antidepressants[1]. Its headline finding was clear: every one of the 21 drugs was more effective than placebo for adults with major depression.

The analysis also showed the drugs are not identical, ranking them on both effectiveness and acceptability so prescribers can match a drug to a person[1]. That nuance matters, because the best antidepressant for you is the one that helps your symptoms with side effects you can live with.

Most People Need More Than One Try

The largest real-world depression study, known as STAR-D, showed that the first antidepressant brings full remission for roughly a third of people[4]. That can sound discouraging until you see the rest of the picture.

Each additional step, whether switching drugs or adding a second treatment, helps more people get well, so the cumulative odds of remission climb as treatment is adjusted[4]. A slow start is information for the next step, not a verdict.

Common and Serious Side Effects

Most side effects fadeThe common early side effects, like nausea and restlessness, often ease within the first couple of weeks as your body adjusts. Telling your prescriber about them usually leads to a simple fix, a dose change or a different drug, not white-knuckling through.

Like any medicine, antidepressants have side effects. Most are mild and fade, a few are worth planning around, and a small number are serious and need fast action.

The Common Side Effects and How Long They Last

The frequent side effects of SSRIs and SNRIs are usually manageable and often temporary[11]. Many ease over the first weeks, and most can be addressed by adjusting the dose or switching drugs rather than stopping treatment altogether[3].

Common effects include:

  • Nausea or stomach upset, usually early and short-lived
  • Headache in the first days
  • Sleep changes, either trouble sleeping or drowsiness
  • Restlessness or jitteriness early on
  • Weight changes with some drugs, while others are weight-neutral[13]
  • Dry mouth and dizziness, more so with older tricyclics[15]

Sexual Side Effects Are Common and Worth Naming

Sexual side effects, including lower desire and difficulty with arousal or orgasm, are among the most common reasons people quietly stop SSRIs[19]. They are real, they are not your imagination, and they are worth raising even though they can feel awkward to bring up.

There are good options. Switching to bupropion, which does not carry these effects, or adjusting the approach can help, and a network meta-analysis confirms antidepressants differ markedly in how often they cause sexual problems[20][13]. For most people the effects ease after stopping, though a minority report lingering symptoms[19].

Serious Reactions Like Serotonin Syndrome

A few side effects are serious and need quick attention. Serotonin syndrome is a rare but dangerous buildup of serotonin activity, usually when two serotonin-raising drugs are combined, and it is a medical emergency[21].

Other serious concerns include a higher risk of bleeding when SSRIs are combined with blood thinners or anti-inflammatory painkillers[8], and the blood-pressure danger of mixing an MAOI with tyramine-rich foods or other drugs[16]. Telling every prescriber and pharmacist what you take is the single best protection against these interactions.

Antidepressants, Young People, and Suicide Risk

Monitoring, not avoidingThe warning is a reason to watch closely in the first weeks, not a reason to refuse treatment. After the warning, prescribing fell and some measures of youth suicide worsened, a reminder that untreated depression is itself dangerous.

This is the most sensitive part of the antidepressant story, and it deserves to be stated plainly rather than avoided. The concern is real, the response is monitoring, and untreated depression carries its own grave danger.

What the FDA Black-Box Warning Says

Antidepressants carry an FDA black-box warning about a small rise in suicidal thoughts and behavior in people under 25, especially in the first weeks of treatment or after a dose change[5]. The warning applies to the whole class and is most relevant for children, teens, and young adults.

The warning is best read for what it is: a signal to monitor early treatment carefully, not evidence that the drugs cause suicide broadly. In children and adolescents, fluoxetine has the strongest evidence and is the usual first choice when medication is needed[22].

Close Monitoring Early, Not Avoiding Treatment

The practical takeaway is steady follow-up in the first weeks, especially for younger patients, so any worsening mood or new agitation is caught quickly[5]. Family members watching for warning signs are part of that safety net.

The alternative, leaving depression untreated, is not safe either. After the warnings were issued, antidepressant prescribing for young people dropped and some measures of youth suicide rose, which underlined that untreated depression is itself a serious risk[5].

Stopping Antidepressants Safely

Discontinuation is not addictionStopping an antidepressant can bring temporary symptoms because your body adjusted to it. That is not addiction. There is no craving and no chasing a high, just a body re-adjusting, which a slow taper smooths out.

One of the most important things to understand is the difference between needing to taper a drug and being addicted to it. Antidepressants ask for a careful exit, but they do not hijack you the way an addictive drug does.

Discontinuation Symptoms Are Not Addiction

Because the body adapts to an antidepressant over time, stopping suddenly can trigger discontinuation syndrome, with symptoms like dizziness, flu-like feelings, irritability, and odd electric-shock sensations[2]. Short-acting drugs like venlafaxine and paroxetine tend to cause this more sharply[12].

This is not addiction. Addiction means craving and compulsive use despite harm, and antidepressants produce neither[2]. What they produce is a body that has adjusted, which is a predictable, manageable medical situation rather than a loss of control.

Tapering Slowly With Your Prescriber

The fix is straightforward: come off gradually under a prescriber’s guidance rather than stopping all at once[2]. A slow, planned step-down lets the body re-adjust with little or no discomfort.

Timing matters too. Stopping too early is a common cause of relapse, so guidelines suggest staying on a working antidepressant for a stretch after you feel better before tapering[23]. When the time is right, the taper is a planned, supervised process, not a leap.

Switching and Augmentation When the First Drug Falls Short

If the first antidepressant does not work or is hard to tolerate, that is common and far from the end of the road. Two well-studied strategies follow: switching the drug, or adding a second one to boost it.

Switching to a Different Antidepressant

Switching means stopping one antidepressant and starting another, often from a different class, and it is a standard move when the first drug brought no real benefit[4]. Because individual drugs differ in effectiveness and tolerability, a second agent can succeed where the first did not[1].

The switch is done with care, since some changes need a gradual cross-taper to avoid interactions. This is routine work for a prescriber, and the sequenced approach in STAR-D showed that moving methodically through options keeps lifting the odds of recovery[4].

Augmenting With a Second Medication

Augmentation means keeping the antidepressant and adding another medication to strengthen it, usually when the first drug helped a little but not enough. Adding an atypical antipsychotic has the most evidence for this[24], and adding lithium is a long-established option[25].

When several adequate trials have failed, the picture is called treatment-resistant depression, and the menu widens to include further augmentation strategies and brain-based treatments like ECT, TMS, and ketamine[26][27]. Ketamine and its nasal-spray form esketamine can ease symptoms within hours to days, a different speed from standard pills[28].

Antidepressant Myths Worth Clearing Up

A lot of fear about antidepressants comes from myths that do not match the evidence. Clearing them up makes the real decision, whether one is right for you, much easier.

They Are Not Addictive or Personality-Changing

The biggest myths are that antidepressants are addictive and that they will change who you are. Neither holds up. They do not cause craving or escalating use, and the need to taper reflects ordinary physical adjustment, not addiction[2].

Myth What the evidence shows
They are happy pills They reduce the symptoms of an illness, they do not manufacture happiness[6]
They work instantly Full benefit usually takes two to six weeks[3]
They are addictive No craving or escalation; you taper to avoid discontinuation symptoms[2]
It is all just low serotonin The serotonin story is incomplete; the drugs work through more than one pathway[9]
If one fails, none will work Switching or augmenting helps most people eventually[4]

They Are Not Instant, and Not a Last Resort

Another pair of myths pulls in opposite directions: that antidepressants should work overnight, and that they are only for the most extreme cases. Both miss the mark. They are first-line care for moderate to severe depression, not a final option, and they ask for a few weeks of patience[1][3].

The serotonin-imbalance line gets oversimplified in both directions too. The mechanism is more complex than a single low chemical[9], and yet the drugs still genuinely help millions of people, which is what matters most when you are deciding whether to try one[1].

Getting Help for Depression

If you are considering an antidepressant, the most useful step is a conversation with a doctor or psychiatrist about your symptoms, your history, and what you want from treatment. Medication is one strong tool, and it works best as part of a plan that often includes therapy[6].

That plan matters even more when depression travels with a substance problem, which is common. Drinking or using to numb low mood tends to deepen it over time, and care that treats the depression and the alcohol or drug use together gives the best odds on both[29].

Your First Step

You do not need to have it all figured out to begin. Ask directly about which antidepressant fits you, how long to expect before it helps, what side effects to watch for, and what to do in a crisis. If the first provider is not a fit, keep looking, because the right care is worth finding.

For the wider picture of the illness these medicines treat, see the overview of depression and how it is treated, where therapy, screening, and recovery are covered alongside medication.

Whatever brought you here, depression is treatable and recovery is the likeliest outcome. Free, confidential help is available right now.

Find treatment that fits your life →

Frequently asked questions

How Long Do Antidepressants Take to Work?

Most antidepressants take about two to six weeks of steady use to show their full effect, so early patience matters[3]. Some people notice small improvements in sleep or energy sooner, while the lift in mood usually comes later. The leading explanation is that the lasting benefit comes from slow changes in the brain’s connections, not just the quick change in brain chemistry[6]. Give a new medication a fair trial of several weeks before judging it, unless side effects make that impossible.

Are Antidepressants Addictive?

No, antidepressants are not addictive in the usual sense. People do not crave them or escalate the dose to chase a high[2]. The body does adjust to them, though, so stopping suddenly can cause temporary discontinuation symptoms, which is why you taper off gradually with a prescriber rather than stopping all at once[2]. That need to taper reflects ordinary physical adjustment, not a loss of control.

What Are the Most Common Antidepressant Side Effects?

The common side effects of SSRIs and SNRIs include nausea, headache, sleep changes, restlessness, and sexual side effects such as lower desire or difficulty with orgasm[11][19]. Many of these ease over the first weeks as the body adjusts, and most can be addressed by changing the dose or switching drugs rather than stopping treatment[3]. Bupropion is a common alternative because it tends not to cause sexual side effects or weight gain[13].

Which Antidepressant Is the Best?

There is no single best antidepressant for everyone. A large network meta-analysis of 21 drugs found all of them more effective than placebo, with meaningful differences between individual agents in how well they work and how easily people stay on them[1]. The best choice for you is the one that eases your symptoms with side effects you can live with, matched to your history and preferences. SSRIs such as sertraline or escitalopram are common first choices.

Do Antidepressants Increase the Risk of Suicide?

Antidepressants carry an FDA black-box warning about a small rise in suicidal thoughts in people under 25, especially in the first weeks of treatment[5]. The practical response is close monitoring early on, not avoiding treatment, because untreated depression is itself a serious risk. After the warnings were issued, prescribing for young people dropped and some measures of youth suicide rose[5]. In children and adolescents, fluoxetine has the strongest evidence[22].

Can You Stop Taking Antidepressants?

Yes, but you stop gradually rather than all at once. Coming off slowly under a prescriber’s guidance lets the body re-adjust with little or no discomfort and avoids discontinuation symptoms[2]. Timing matters too, because stopping too early is a common cause of relapse, so guidelines suggest staying on a working antidepressant for a stretch after you feel better before tapering[23]. When the time is right, the taper is a planned, supervised process.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

29 Sources
  1. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al (2018). Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. Focus (American Psychiatric Publishing). https://doi.org/10.1176/appi.focus.16407
  2. Wisłowska-Stanek A, Jarkiewicz M, Mirowska-Guzel D (2025). Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders. Pharmacological reports : PR. https://doi.org/10.1007/s43440-024-00689-z
  3. David DJ, Gourion D (2016). [Antidepressant and tolerance: Determinants and management of major side effects]. L'Encephale. https://doi.org/10.1016/j.encep.2016.05.006
  4. Sinyor M, Schaffer A, Levitt A (2010). The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Canadian journal of psychiatry. Revue canadienne de psychiatrie. https://doi.org/10.1177/070674371005500303
  5. Soumerai SB, Koppel R, Naci H, Madden JM, Fry A, Halbisen A, et al (2024). Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings: A Systematic Review. Health affairs (Project Hope). https://doi.org/10.1377/hlthaff.2023.00263
  6. Esalatmanesh S, Kashani L, Akhondzadeh S (2023). Effects of Antidepressant Medication on Brain-derived Neurotrophic Factor Concentration and Neuroplasticity in Depression: A Review of Preclinical and Clinical Studies. Avicenna journal of medical biotechnology. https://doi.org/10.18502/ajmb.v15i3.12921
  7. Birkinshaw H, Friedrich CM, Cole P, Eccleston C, Serfaty M, Stewart G, et al (2023). Antidepressants for pain management in adults with chronic pain: a network meta-analysis. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd014682.pub2
  8. Edinoff AN, Raveendran K, Colon MA, Thomas BH, Trettin KA, Hunt GW, et al (2022). Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review. Health psychology research. https://doi.org/10.52965/001c.39580
  9. Carmellini P, Cuomo A, Rescalli MB, Pinzi M, Dourmas A, Fagiolini A (2026). The Monoamine-Glutamate Continuum of Depression: A Neurobiological Framework for Precision Psychiatry. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19050662
  10. Bulek D, BaDour S (2026). From monoamine deficits to multiscale plasticity: twenty-five years of ketamine and the neurophysiology of depression. Journal of neurophysiology. https://doi.org/10.1152/jn.00516.2025
  11. Ferguson JM (2001). SSRI Antidepressant Medications: Adverse Effects and Tolerability. Primary care companion to the Journal of clinical psychiatry. https://doi.org/10.4088/pcc.v03n0105
  12. Holland J, Brown R (2017). Neonatal venlafaxine discontinuation syndrome: A mini-review. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. https://doi.org/10.1016/j.ejpn.2016.11.003
  13. Demyttenaere K, Jaspers L (2008). Review: Bupropion and SSRI-induced side effects. Journal of psychopharmacology (Oxford, England). https://doi.org/10.1177/0269881107083798
  14. Caiazza C, Rago V, Solini N, Franzese L, Lusciano F, Mazza D, et al (2026). Clinical Potential of Mirtazapine in Anxiety and Trauma-Related Disorders: A Systematic Review and Meta-Analysis of Current Evidence. Human psychopharmacology. https://doi.org/10.1002/hup.70037
  15. Kutzer T, Dick M, Scudamore T, Wiener M, Schwartz T (2020). Antidepressant efficacy and side effect burden: an updated guide for clinicians. Drugs in context. https://doi.org/10.7573/dic.2020-2-2
  16. Rached Gl, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, et al (2026). Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data. CNS drugs. https://doi.org/10.1007/s40263-025-01256-7
  17. Cuomo A, Pompili M, Vita A, Spina E, Caraci F, Fagiolini A (2026). A narrative review on trazodone as a multimodal and multifunctional antidepressant: clinical relevance of formulations, dosing, and pharmacokinetic/pharmacodynamic targets. Annals of general psychiatry. https://doi.org/10.1186/s12991-026-00643-8
  18. Barbosa EC, da Silva GHS, Sbardelotto nEEn, Barroso DC, de Lima FR, E Paez LEF, et al (2024). Vortioxetine versus reuptake inhibitors in adults with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials. Asian journal of psychiatry. https://doi.org/10.1016/j.ajp.2024.104222
  19. Peleg LC, Rabinovitch D, Lavie Y, Rabbie DM, Horowitz I, Fruchter E, et al (2022). Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors. Sexual medicine reviews. https://doi.org/10.1016/j.sxmr.2021.07.001
  20. Wang Q, Xu Z, Chen X, Liu L, Liu X (2025). Effect of antidepressants on ejaculation dysfunction in patients with depression and anxiety: A systematic review and network meta-analysis. Andrology. https://doi.org/10.1111/andr.13770
  21. Kyi WW, Peter EB, Carter K, Otaru JO, Wai HHH (2025). Delayed Serotonin Syndrome Following the Concurrent Use of an Unregulated Supplement and Selective Serotonin Reuptake Inhibitors (SSRIs): A Case Report. Cureus. https://doi.org/10.7759/cureus.93768
  22. Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, et al (2016). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England). https://doi.org/10.1016/s0140-6736(16)30385-3
  23. Breedvelt JJF, Warren FC, Segal Z, Kuyken W, Bockting CL (2021). Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2021.0823
  24. Papakostas GI, Shelton RC, Smith J, Fava M (2007). Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. The Journal of clinical psychiatry. https://doi.org/10.4088/jcp.v68n0602
  25. Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C (2014). A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression. Journal of affective disorders. https://doi.org/10.1016/j.jad.2014.05.053
  26. Saelens J, Gramser A, Watzal V, Zarate CA, Lanzenberger R, Kraus C (2025). Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-02044-5
  27. Nuñez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, et al (2022). Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. Journal of affective disorders. https://doi.org/10.1016/j.jad.2021.12.134
  28. Seshadri A, Prokop LJ, Singh B (2024). Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. Journal of affective disorders. https://doi.org/10.1016/j.jad.2024.03.137
  29. Bahji A, Tang V, Danilewitz M (2025). Integrated Management of Co-Occurring Alcohol Use Disorder and Depression: Clinical Approaches for Concurrent Disorders. Canadian journal of psychiatry. Revue canadienne de psychiatrie. https://doi.org/10.1177/07067437251374564
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.